Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

The Weill Family Foundation is giving $50 million to enable 4 leading research institutions to form the Weill Cancer Hub East ...

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on immunotherapy.

The FDA recently approved an immunotherapy-based treatment option that can be administered by under the skin, injection. This ...

The funds will establish the Weill Cancer Hub East, a partnership among Princeton University, the Rockefeller University, Weill Cornell Medicine and the Ludwig Institute for Cancer Research aimed at ...

Odds for desensitization and remission fell as patients missed consecutive doses of peanut oral immunotherapy, according to a ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

Alan Tan, MD, discusses the 8-year follow-up data from the CheckMate 214 trial of patients with advanced renal cell carcinoma.

Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal ...

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...